calcium polystyrene sulfonate powder sugar free
roma pharmaceuticals ltd - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram
calcium polystyrene sulfonate powder sugar free
alliance healthcare (distribution) ltd - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram
calcium polystyrene sulfonate "np" bulk powder (ポリスチレンスルホン酸ca「np」原末)
nipro corporation - calcium polystyrene sulfonate - faint yellowish-white to pale yellow powdered medicine
calcium polystyrene sulfonate 20% oral jelly divided package 25g "sanwa" (ポリスチレンスルホン酸ca経口ゼリー20%分包25g「三和」)
sanwa kagaku kenkyusho co.,ltd. - calcium polystyrene sulfonate - pale yellowish white to pale yellow jelly
calcium polystyrene sulfonate "kyorin" powder (ポリスチレンスルホン酸ca「杏林」原末)
kyorin rimedio co.,ltd. - calcium polystyrene sulfonate - faintly yellowish white to pale yellow powder
calcium resonium powder
lexon (uk) ltd - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram
calcium resonium 99.934 % powder for oral or rectal suspension
sanofi-aventis ireland limited t/a sanofi - calcium polystyrene sulphonate - powder for oral/rectal suspension - 99.934 percent weight/weight - drugs for treatment of hyperkalemia and hyperphosphatemia; polystyrene sulfonate
sodium polystyrene sulfonate suspension
cmp pharma, inc. - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium polystyrene sulfonate 15 g in 60 ml - sps® suspension is contraindicated in the following conditions: patients with hypokalemia, patients with a history of hypersensitivity to polystyrene sulfonate resins, obstructive bowel disease, oral or rectal administration in neonates (see precautions ).
sodium polystyrene sulfonate suspension
cardinal health 107, llc - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium polystyrene sulfonate 15 g in 60 ml - sps® suspension is contraindicated in the following conditions: patients with hypokalemia, patients with a history of hypersensitivity to polystyrene sulfonate resins, obstructive bowel disease, oral or rectal administration in neonates (see precautions ).
sodium polystyrene sulfonate powder, for suspension
belcher pharmaceuticals, llc - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium cation 4.1 meq in 1 g - sodium polystyrene sulfonate for suspension is indicated for the treatment of hyperkalemia. sodium polystyrene sulfonate for suspension is contraindicated in the following conditions: patients with hypokalemia, patients with a history of hypersensitivity to polystyrene sulfonate resins, obstructive bowel disease, neonates with reduced gut motility (postoperatively or drug induced) and oral administration in neonates (see precautions).